Nucleoside-Diphosphate Kinase
"Nucleoside-Diphosphate Kinase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.
Descriptor ID |
D009701
|
MeSH Number(s) |
D08.811.913.696.650.550
|
Concept/Terms |
Nucleoside-Diphosphate Kinase- Nucleoside-Diphosphate Kinase
- Kinase, Nucleoside-Diphosphate
- Nucleoside Diphosphate Kinase
- Nucleoside Diphosphokinases
- Diphosphokinases, Nucleoside
- Deoxynucleoside Diphosphate Kinases
- Diphosphate Kinases, Deoxynucleoside
- Kinases, Deoxynucleoside Diphosphate
- Nucleoside-Diphosphate Kinases
- Kinases, Nucleoside-Diphosphate
- Nucleoside Diphosphate Kinases
|
Below are MeSH descriptors whose meaning is more general than "Nucleoside-Diphosphate Kinase".
Below are MeSH descriptors whose meaning is more specific than "Nucleoside-Diphosphate Kinase".
This graph shows the total number of publications written about "Nucleoside-Diphosphate Kinase" by people in this website by year, and whether "Nucleoside-Diphosphate Kinase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nucleoside-Diphosphate Kinase" by people in Profiles.
-
van Golen KL, Risin S, Staroselsky A, Berger D, Tainsky MA, Pathak S, Price JE. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones. Clin Exp Metastasis. 1996 Mar; 14(2):95-106.